NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
Show detailsBibliographic details: Ma YY, Guan TP, Yao HB, Yu S, Chen LG, Xia YJ, He XJ, Wang HJ, Jiang XT, Tao HQ. The MDM2 309T>G polymorphism and ovarian cancer risk: a meta-analysis of 1534 cases and 2211 controls. PLOS ONE 2013; 8(1): e55019. [PMC free article: PMC3561416] [PubMed: 23383041]
Abstract
BACKGROUND: Recently, there have been a number of studies on the association between MDM2 (Murine Double Minute 2) 309 polymorphism and ovarian cancer risk. However, the results of previous reports remain controversial and ambiguous. Thus, we performed a meta-analysis to explore more precisely the association between MDM2 309 polymorphism and the risk of ovarian cancer.
METHODS: A meta-analysis was performed to examine the association between MDM2 309T>G polymorphism and ovarian cancer risk. Odds ratio (OR) and its 95% confidence interval (CI) were used for statistical analysis.
RESULTS: Our publication search identified a total of 6 studies with 1534 cases and 2211 controls. No significant association was found between MDM2 309T>G polymorphism and ovarian cancer risk in total population analysis. In the subgroup meta-analysis by ethnicity, a negative association was shown in Asian subgroup (G vs. T OR = 0.774, 95% CI = 0.628-0.955, P = 0.017, P(het) = 0.327; GG vs. TT: OR = 0.601, 95% CI = 0.395-0.914, P = 0.017, P(het) = 0.417; dominant model TG+GG vs. TT: OR = 0.661, 95% CI = 0.468-0.934, P = 0.019, P(het) = 0.880), and no significant association in any genetic models among Caucasians was observed.
CONCLUSIONS: This meta-analysis provides evidence for the association between MDM2 309 polymorphism and ovarian cancer risk, supporting the hypothesis that MDM2 SNP309 G allele acts as an important ovarian cancer protective factor in Asians but not in Caucasians.
- MDM2 309T>G polymorphism and risk of squamous cell carcinomas of head and neck: a meta-analysis.[Asian Pac J Cancer Prev. 2011]MDM2 309T>G polymorphism and risk of squamous cell carcinomas of head and neck: a meta-analysis.Liu J, Zheng Y, Lei D, Liu D, Xu F, Jin T, Cao X, Zhao X, Yu X, Pan X. Asian Pac J Cancer Prev. 2011; 12(8):1899-903.
- MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis.[Arch Med Res. 2011]MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis.Liu GY, Jiang DK, Shen SQ, Yu L. Arch Med Res. 2011 Feb; 42(2):149-55.
- Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.[Medicine (Baltimore). 2016]Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.Ding H, Dai Y, Ning Z, Fan N, Wang Z, Li P, Zhang L, Tao Y, Wang H. Medicine (Baltimore). 2016 Mar; 95(12):e2941.
- Review MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.[Hum Cell. 2011]Review MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.Li Y, Zhao H, Sun L, Huang L, Yang Q, Kong B. Hum Cell. 2011 Jun; 24(2):57-64. Epub 2011 Mar 4.
- Review Association of MDM2 gene SNP 309 polymorphism and human non-small cell lung cancer susceptibility: A meta-analysis.[Pathol Res Pract. 2019]Review Association of MDM2 gene SNP 309 polymorphism and human non-small cell lung cancer susceptibility: A meta-analysis.Luan L, Wang H, Zhao B, Wang F, Shi J, Xu X. Pathol Res Pract. 2019 Sep; 215(9):152538. Epub 2019 Jul 13.
- The MDM2 309T>G polymorphism and ovarian cancer risk: a meta-analysis of 1534 ca...The MDM2 309T>G polymorphism and ovarian cancer risk: a meta-analysis of 1534 cases and 2211 controls - Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews
Your browsing activity is empty.
Activity recording is turned off.
See more...